Neurocrine Biosciences
NBIX
#1297
Rank
โ‚ฌ15.30 B
Marketcap
152,25ย โ‚ฌ
Share price
3.87%
Change (1 day)
38.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.4653% (annualized)

Shares available to borrow: 2600000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2026 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Pfizer
PFE
0.4135%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.2712%5.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.2664%3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0.4135%0.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.2695%0.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
13.5668%0.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.2652%6.3 M๐Ÿ‡ฌ๐Ÿ‡ง UK